Back to User profile » Dr Yong Luo
Paper published by Dr Yong Luo:
Clinical Trial Report
Technology, Treatments and Therapeutics
Polyethylene Glycol Loxenatide Selectively Reduces Adiposity While Preserving Lean Body Mass in Type 2 Diabetes: A 12-Week Clinical Study
Gu R, Zhou Y, Kong X, Luo Y, Li H, Ma J
Diabetes, Metabolic Syndrome and Obesity 2026, 19:592044
Published Date: 10 July 2026